Does the media favor MMSI or CNMD?

In the previous week, Merit Medical Systems had 6 more articles in the media than CONMED. MarketBeat recorded 11 mentions for Merit Medical Systems and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Merit Medical Systems' score of 0.83 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MMED or CNMD?

In the previous week, CONMED had 3 more articles in the media than MiniMed Group. MarketBeat recorded 5 mentions for CONMED and 2 mentions for MiniMed Group. CONMED's average media sentiment score of 1.23 beat MiniMed Group's score of 0.67 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, LIVN or CNMD?

CONMED has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivaNova $1.39B 3.02 -$242.47M $3.38 22.55 CONMED $1.37B 1.07 $47.06M $1.85 26.48

Is LIVN or CNMD more profitable?

LivaNova has a net margin of 12.82% compared to CONMED's net margin of 4.12%. LivaNova's return on equity of 16.35% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets LivaNova 12.82% 16.35% 7.76% CONMED 4.12% 14.31% 6.33%

Does the media favor LIVN or CNMD?

In the previous week, LivaNova had 11 more articles in the media than CONMED. MarketBeat recorded 16 mentions for LivaNova and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat LivaNova's score of 0.76 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 6 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, CNMD or ITGR?

Integer has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 1.07 $47.06M $1.85 26.48 Integer $1.85B 2.29 $102.81M $3.66 34.17

Is CNMD or ITGR more profitable?

Integer has a net margin of 6.97% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets CONMED 4.12% 14.31% 6.33% Integer 6.97% 12.79% 6.48%

Does the media prefer CNMD or ITGR?

In the previous week, Integer had 27 more articles in the media than CONMED. MarketBeat recorded 32 mentions for Integer and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Integer's score of 0.72 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 17 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, CNMD or HAE?

Haemonetics has lower revenue, but higher earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 1.07 $47.06M $1.85 26.48 Haemonetics $1.35B 2.94 $97.31M $2.04 42.89

Is CNMD or HAE more profitable?

Haemonetics has a net margin of 7.12% compared to CONMED's net margin of 4.12%. Haemonetics' return on equity of 27.55% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets CONMED 4.12% 14.31% 6.33% Haemonetics 7.12% 27.55% 9.65%

Does the media prefer CNMD or HAE?

In the previous week, Haemonetics had 24 more articles in the media than CONMED. MarketBeat recorded 29 mentions for Haemonetics and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Haemonetics' score of 0.71 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 7 Very Positive mention(s) 4 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

CONMED (CNMD) Competitors

$48.99 -0.13 (-0.26%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$49.12 +0.13 (+0.26%)

As of 08/7/2026 07:58 PM Eastern

Compare

CNMD vs. MMSI, MMED, LIVN, ITGR, and HAE

Should you buy CONMED stock or one of its competitors? MarketBeat compares CONMED with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CONMED include Merit Medical Systems (MMSI), MiniMed Group (MMED), LivaNova (LIVN), Integer (ITGR), and Haemonetics (HAE). These companies are all part of the "healthcare equipment & supplies" industry.

How does CONMED compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

Merit Medical Systems currently has a consensus price target of $100.30, suggesting a potential upside of 12.65%. CONMED has a consensus price target of $41.40, suggesting a potential downside of 15.50%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities analysts plainly believe Merit Medical Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

Merit Medical Systems has a net margin of 9.22% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
CONMED	4.12%	14.31%	6.33%

Merit Medical Systems has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.51	$128.49M	$2.42	36.79
CONMED	$1.37B	1.07	$47.06M	$1.85	26.48

Merit Medical Systems has a beta of 0.48, suggesting that its stock price is 52% less volatile than the broader market. Comparatively, CONMED has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

In the previous week, Merit Medical Systems had 6 more articles in the media than CONMED. MarketBeat recorded 11 mentions for Merit Medical Systems and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Merit Medical Systems' score of 0.83 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.7% of Merit Medical Systems shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Merit Medical Systems beats CONMED on 13 of the 16 factors compared between the two stocks.

How does CONMED compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

In the previous week, CONMED had 3 more articles in the media than MiniMed Group. MarketBeat recorded 5 mentions for CONMED and 2 mentions for MiniMed Group. CONMED's average media sentiment score of 1.23 beat MiniMed Group's score of 0.67 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group currently has a consensus price target of $21.62, suggesting a potential upside of 10.28%. CONMED has a consensus price target of $41.40, suggesting a potential downside of 15.50%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe MiniMed Group is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

CONMED has a net margin of 4.12% compared to MiniMed Group's net margin of 0.00%. CONMED's return on equity of 14.31% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
CONMED	4.12%	14.31%	6.33%

CONMED has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.77	-$333M	-$0.68	N/A
CONMED	$1.37B	1.07	$47.06M	$1.85	26.48

Summary

CONMED beats MiniMed Group on 8 of the 13 factors compared between the two stocks.

How does CONMED compare to LivaNova?

LivaNova (NASDAQ:LIVN) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, CONMED has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

97.6% of LivaNova shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

LivaNova currently has a consensus price target of $83.50, indicating a potential upside of 9.55%. CONMED has a consensus price target of $41.40, indicating a potential downside of 15.50%. Given LivaNova's stronger consensus rating and higher probable upside, research analysts plainly believe LivaNova is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63

LivaNova has a net margin of 12.82% compared to CONMED's net margin of 4.12%. LivaNova's return on equity of 16.35% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
CONMED	4.12%	14.31%	6.33%

CONMED has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.02	-$242.47M	$3.38	22.55
CONMED	$1.37B	1.07	$47.06M	$1.85	26.48

In the previous week, LivaNova had 11 more articles in the media than CONMED. MarketBeat recorded 16 mentions for LivaNova and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat LivaNova's score of 0.76 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	6 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LivaNova beats CONMED on 13 of the 17 factors compared between the two stocks.

How does CONMED compare to Integer?

CONMED (NYSE:CNMD) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

99.3% of Integer shares are owned by institutional investors. 0.3% of CONMED shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Integer had 27 more articles in the media than CONMED. MarketBeat recorded 32 mentions for Integer and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Integer's score of 0.72 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	17 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED currently has a consensus target price of $41.40, indicating a potential downside of 15.50%. Integer has a consensus target price of $109.86, indicating a potential downside of 12.16%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

CONMED has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Integer has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

Integer has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.07	$47.06M	$1.85	26.48
Integer	$1.85B	2.29	$102.81M	$3.66	34.17

Integer has a net margin of 6.97% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Integer	6.97%	12.79%	6.48%

Summary

Integer beats CONMED on 13 of the 16 factors compared between the two stocks.

How does CONMED compare to Haemonetics?

CONMED (NYSE:CNMD) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Haemonetics has lower revenue, but higher earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.07	$47.06M	$1.85	26.48
Haemonetics	$1.35B	2.94	$97.31M	$2.04	42.89

Haemonetics has a net margin of 7.12% compared to CONMED's net margin of 4.12%. Haemonetics' return on equity of 27.55% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Haemonetics	7.12%	27.55%	9.65%

99.7% of Haemonetics shares are owned by institutional investors. 0.3% of CONMED shares are owned by insiders. Comparatively, 2.1% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Haemonetics had 24 more articles in the media than CONMED. MarketBeat recorded 29 mentions for Haemonetics and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Haemonetics' score of 0.71 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	7 Very Positive mention(s)	4 Positive mention(s)	12 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

CONMED presently has a consensus price target of $41.40, indicating a potential downside of 15.50%. Haemonetics has a consensus price target of $90.89, indicating a potential upside of 3.87%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts plainly believe Haemonetics is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

Haemonetics beats CONMED on 14 of the 17 factors compared between the two stocks.

Get CONMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNMD vs. The Competition

Export

Metric	CONMED	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.47B	$5.86B	$7.02B	$24.18B
Dividend Yield	N/A	1.78%	2.58%	3.69%
P/E Ratio	26.48	24.26	270.57	29.13
Price / Sales	1.07	68.30	599.88	19.16
Price / Cash	6.82	33.55	28.89	19.37
Price / Book	1.47	6.11	11.21	4.91
Net Income	$47.06M	$149.01M	$3.45B	$1.06B
7 Day Performance	-5.65%	2.54%	3.41%	1.65%
1 Month Performance	27.47%	0.78%	-0.71%	2.63%
1 Year Performance	-10.45%	4.93%	77.31%	20.40%

CONMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNMD CONMED	2.7395 of 5 stars	$48.99 -0.3%	$41.40 -15.5%	-10.4%	$1.47B	$1.37B	26.48	3,900	Positive News
MMSI Merit Medical Systems	3.3423 of 5 stars	$85.53 +0.6%	$100.30 +17.3%	+4.0%	$5.08B	$1.52B	35.34	7,500
MMED MiniMed Group	2.3078 of 5 stars	$19.10 +5.8%	$21.62 +13.2%	N/A	$5.36B	$3.10B	N/A	8,000	Gap Up
LIVN LivaNova	3.1301 of 5 stars	$82.46 +2.9%	$81.38 -1.3%	+56.1%	$4.40B	$1.39B	42.29	3,300	Positive News Earnings Report
ITGR Integer	2.3794 of 5 stars	$124.45 +2.7%	$103.71 -16.7%	+17.5%	$4.12B	$1.85B	31.03	11,000	Earnings Report High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNMD) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONMED (CNMD) Competitors

CNMD vs. MMSI, MMED, LIVN, ITGR, and HAE

How does CONMED compare to Merit Medical Systems?

Summary

How does CONMED compare to MiniMed Group?

Summary

How does CONMED compare to LivaNova?

Summary

How does CONMED compare to Integer?

Summary

How does CONMED compare to Haemonetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CONMED (CNMD) Competitors

CNMD vs. MMSI, MMED, LIVN, ITGR, and HAE

How does CONMED compare to Merit Medical Systems?

Do analysts prefer MMSI or CNMD?

Is MMSI or CNMD more profitable?

Which has stronger earnings & valuation, MMSI or CNMD?

Which has more risk and volatility, MMSI or CNMD?

Does the media favor MMSI or CNMD?

Do insiders & institutionals hold more shares of MMSI or CNMD?

Summary

How does CONMED compare to MiniMed Group?

Does the media refer more to MMED or CNMD?

Do analysts recommend MMED or CNMD?

Is MMED or CNMD more profitable?

Which has better earnings & valuation, MMED or CNMD?

Summary

How does CONMED compare to LivaNova?

Which has more volatility & risk, LIVN or CNMD?

Do insiders and institutionals believe in LIVN or CNMD?

Do analysts recommend LIVN or CNMD?

Is LIVN or CNMD more profitable?

Which has preferable earnings & valuation, LIVN or CNMD?

Does the media favor LIVN or CNMD?

Summary

How does CONMED compare to Integer?

Do insiders & institutionals believe in CNMD or ITGR?

Does the media prefer CNMD or ITGR?

Do analysts recommend CNMD or ITGR?

Which has more volatility and risk, CNMD or ITGR?

Which has higher valuation & earnings, CNMD or ITGR?

Is CNMD or ITGR more profitable?

Summary

How does CONMED compare to Haemonetics?

Which has preferable earnings and valuation, CNMD or HAE?

Is CNMD or HAE more profitable?

Do institutionals and insiders believe in CNMD or HAE?

Does the media prefer CNMD or HAE?

Which has more risk & volatility, CNMD or HAE?

Do analysts prefer CNMD or HAE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools